Thyroid and Other Autoimmune Diseases with Emphasis on Type 1 Diabetes Mellitus and Turner Syndrome

Author(s):  
Thomas Kapellen ◽  
Angela Galler ◽  
Roland Pfäffle ◽  
Wieland Kiess
2020 ◽  
Vol 11 ◽  
pp. 204201882095832
Author(s):  
Liyan Li ◽  
Shudong Liu ◽  
Junxia Yu

Autoimmune thyroid disease (AITD) and type 1 diabetes mellitus (T1DM) are two common autoimmune diseases that can occur concomitantly. In general, patients with diabetes have a high risk of AITD. It has been proposed that a complex genetic basis together with multiple nongenetic factors make a variable contribution to the pathogenesis of T1DM and AITD. In this paper, we summarize current knowledge in the field regarding potential pathogenic factors of T1DM and AITD, including human leukocyte antigen, autoimmune regulator, lymphoid protein tyrosine phosphatase, forkhead box protein P3, cytotoxic T lymphocyte-associated antigen, infection, vitamin D deficiency, and chemokine (C-X-C motif) ligand. These findings offer an insight into future immunotherapy for autoimmune diseases.


2000 ◽  
Vol 53 (5) ◽  
pp. 649-653 ◽  
Author(s):  
Giuliana Valerio ◽  
Adriana Franzesé Andrea Iovino ◽  
Michela Tanga ◽  
Maria Alessio ◽  
Claudio Pignata

2015 ◽  
Vol 12 (4) ◽  
Author(s):  
Nesibe Akyürek ◽  
Mehmet Emre Atabek ◽  
Beray Selver Eklioğlu

2013 ◽  
Vol 59 (1) ◽  
pp. 35-43 ◽  
Author(s):  
A A Larina ◽  
E A Troshina

Type 1 diabetes mellitus is not infrequently associated with other autoimmune endocrine and non-endocrine diseases included in the notion of "autoimmune polyglandular syndrome" (APS). Their incidence in the patients presenting with this syndrome is significantly higher than that of isolated autoimmune pathologies. The enhanced risk of the development of these diseases is associated with the presence of genetic markers, such as HLAII-complex haplotypes, CTLA-4, PTPN22, FOXP2, and certain other genes. Decompensation of autoimmune thyroid disorders and adrenal insufficiency, as well as the presence of celiac disease, autoimmune gastritis and pernicious anemia in the patients with type 1 diabetes mellitus may be responsible for the impairment of metabolic control. It is recommended that the patients with DM1 be regularly examined for the early diagnostics of autoimmune diseases including components of APS and the associated subclinical functional disturbances with a view to preventing deterioration of metabolic control.


2021 ◽  
Vol 47 (1) ◽  
Author(s):  
Maria Francesca Gicchino ◽  
Dario Iafusco ◽  
Angela Zanfardino ◽  
Emanuele Miraglia del Giudice ◽  
Alma Nunzia Olivieri

Abstract Background Type 1 diabetes mellitus could be associated with other autoimmune diseases, such as autoimmune thyroid disease, celiac disease, but the association with Familial Mediterranean Fever is rare, we describe a case of a boy with type 1 Diabetes Mellitus associated with Familial Mediterranean Fever (FMF). Case presentation A 13 year old boy already suffering from Diabetes Mellitus type 1 since the age of 4 years, came to our attention because of periodic fever associated with abdominal pain, chest pain and arthralgia. The fever appeared every 15–30 days with peaks that reached 40 °C and lasted 24–48 h. Laboratory investigation, were normal between febrile episodes, but during the attacks revealed an increase in inflammatory markers. Suspecting Familial Mediterranean Fever molecular analysis of MEFV gene, was performed. The genetic analysis showed homozygous E148Q mutation. So Familial Mediterranean Fever was diagnosed and colchicine treatment was started with good response. Conclusion Familial Mediterranean Fever could be associated with other autoimmune diseases such as Ankylosing Spondylitis, Rheumatoid Arthritis, Polyarteritis Nodosa, Behcet disease, Systemic Lupus, Henoch-Schönlein Purpura, and Hashimoto’s Thyroiditis. Association of type 1 Diabetes Mellitus and Familial Mediterranean Fever has been newly reported in the medical literature, this is the third association of these two diseases described in the medical literature so far.


2015 ◽  
Vol 14 (9) ◽  
pp. 781-797 ◽  
Author(s):  
Kostas Kakleas ◽  
Alexandra Soldatou ◽  
Feneli Karachaliou ◽  
Kyriaki Karavanaki

Sign in / Sign up

Export Citation Format

Share Document